Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/16/05 → 2/28/09 |
02-GI-68IS-BM Clinical Protocol CA225006: A Phase III Randomized, Open-Label Multicenter Study of Irinotecan and Celtuximab vs. Irinotecan as Second-Line Treatment in Patients With Metastic, EGFR-Positive
- DeSimone, Philip (PI)